6-(2-(Ethylamino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol
[CAS# 722520-42-5]

Identification

• Classification: Pharmaceutical intermediate >> Heterocyclic compound intermediate >> Pyrimidine compound >> Alcohol
• Name: 6-(2-(Ethylamino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol
• Molecular Formula: C₁₉H₂₃NO₂
• Molecular Weight: 297.39
• CAS Registry Number: 722520-42-5
• SMILES: CCNC1=C(C=CC(=C1)OC)C2CCC3=C(C2)C=CC(=C3)O

Discovory and Applicatios

6-(2-(Ethylamino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol is a compound with a promising pharmacological profile, owing to its unique structural features that combine a tetrahydronaphthalene backbone with functional groups such as an ethylamino and methoxy group. The ethylamino and methoxy substitutions on the aromatic ring enhance its biological activity by modulating interactions with various cellular targets. This structure provides a platform for the development of bioactive molecules, potentially offering new avenues for therapeutic intervention.

The compound's synthesis involves the functionalization of a tetrahydronaphthalene core, which is typically accomplished via selective aromatic substitution reactions. These reactions allow the introduction of the ethylamino and methoxy groups at specific positions on the phenyl ring, creating a compound with distinct biological properties. This method provides a straightforward approach to achieving the desired structure and ensures the stability and reactivity of the final product.

6-(2-(Ethylamino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol has potential applications in the fields of medicinal chemistry and drug development. Its structural features suggest it may be useful in designing compounds targeting the central nervous system or other receptor systems. The hydroxyl group in its structure also points to possible applications in modulating inflammatory pathways, potentially serving as a lead for new treatments for neurological or inflammatory disorders.

This compound may be of particular interest in the development of drugs that aim to regulate neurotransmitter activity or modulate specific receptors involved in brain function. Further studies would be required to fully explore its therapeutic potential and refine its application in disease treatment.